Literature DB >> 25483533

Adult vaccination.

Kena A Swanson1, H Josef Schmitt, Kathrin U Jansen, Annaliesa S Anderson.   

Abstract

Vaccination of children has had a major impact on the morbidity and mortality of many infectious diseases globally. However, with age, immune responses to vaccines can be less robust, which can be further enhanced by underlying diseases that are common in the older adult. In many countries around the globe booster vaccinations against diphtheria, tetanus, and pertussis are recommended for adults. For the older adult, vaccination against pneumococcal diseases, influenza and herpes zoster are also recommended. Despite these recommendations, the widespread use of these vaccines in the adult population clearly lags behind the vaccine uptake and successes documented for pediatric vaccination programs. Furthermore, extensive and sometimes inappropriate use of antibiotics have fostered the emergence of antibiotic-resistant bacteria (e.g., methicillin resistant Staphylococcus aureus (MRSA)) as well as increased susceptibility in the elderly to bacterial species such as Clostridium difficile. Infectious diseases remain an important unmet medical need and new concepts to successfully implement vaccination of adults are urgently needed.

Entities:  

Keywords:  Clostridium difficile; Staphylococcus aureus; infectious disease; pneumococcal disease; vaccine

Mesh:

Substances:

Year:  2014        PMID: 25483533      PMCID: PMC4514418          DOI: 10.4161/hv.35858

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  58 in total

1.  The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence.

Authors:  Eili Y Klein; Ramanan Laxminarayan
Journal:  Future Microbiol       Date:  2013-07       Impact factor: 3.165

Review 2.  Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe.

Authors:  David S Fedson; Laurence Nicolas-Spony; Peter Klemets; Mark van der Linden; Agostinho Marques; Luis Salleras; Sandrine I Samson
Journal:  Expert Rev Vaccines       Date:  2011-08-03       Impact factor: 5.217

3.  Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Authors:  Anneke Steens; Marianne A Riise Bergsaker; Ingeborg S Aaberge; Karin Rønning; Didrik F Vestrheim
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

4.  Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Authors:  Santiago M Lattar; Mariángeles Noto Llana; Philippe Denoël; Sophie Germain; Fernanda R Buzzola; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

5.  Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice.

Authors:  Ravi P N Mishra; Paolo Mariotti; Luigi Fiaschi; Sarah Nosari; Silvia Maccari; Sabrina Liberatori; Maria Rita Fontana; Alfredo Pezzicoli; Maria Grazia De Falco; Fabiana Falugi; Emrah Altindis; Davide Serruto; Guido Grandi; Fabio Bagnoli
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

6.  Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Authors:  Vance G Fowler; Keith B Allen; Edson D Moreira; Moustafa Moustafa; Frank Isgro; Helen W Boucher; G Ralph Corey; Yehuda Carmeli; Robert Betts; Jonathan S Hartzel; Ivan S F Chan; Tessie B McNeely; Nicholas A Kartsonis; Dalya Guris; Matthew T Onorato; Steven S Smugar; Mark J DiNubile; Ajoke Sobanjo-ter Meulen
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

7.  Staphylococcal Esx proteins modulate apoptosis and release of intracellular Staphylococcus aureus during infection in epithelial cells.

Authors:  Charalampia G Korea; Giuliana Balsamo; Alfredo Pezzicoli; Christina Merakou; Simona Tavarini; Fabio Bagnoli; Davide Serruto; Meera Unnikrishnan
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

8.  Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia.

Authors:  Jan Törling; Jonas Hedlund; Helle Bossen Konradsen; Ake Ortqvist
Journal:  Vaccine       Date:  2003-12-08       Impact factor: 3.641

9.  Pneumococcal conjugate vaccine for adults: a new paradigm.

Authors:  Peter R Paradiso
Journal:  Clin Infect Dis       Date:  2012-04-11       Impact factor: 9.079

10.  Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus.

Authors:  Jasdeep S Nanra; Sandra M Buitrago; Shomari Crawford; Jennifer Ng; Pamela S Fink; Julio Hawkins; Ingrid L Scully; Lisa K McNeil; José Miguel Aste-Amézaga; David Cooper; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

View more
  8 in total

1.  Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study.

Authors:  Aziz Ahmad Hamidi; Beray Gelmez Taş; Alper Gündüz; Safiye Nur Çelebi; Elif Serap Esen; Dilek Toprak; İlyas Dökmetaş
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

Review 2.  Possible immunosuppressive effects of drug exposure and environmental and nutritional effects on infection and vaccination.

Authors:  H P Huemer
Journal:  Mediators Inflamm       Date:  2015-04-05       Impact factor: 4.711

Review 3.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

Review 4.  The Burden of Invasive Vaccine-Preventable Diseases in Adults in the Middle East and North Africa (MENA) Region.

Authors:  Abdul Rahman Bizri; Abdulhakeem Althaqafi; Nawal Kaabi; Nathir Obeidat; Nadine Al Akoury; Hammam Haridy
Journal:  Infect Dis Ther       Date:  2021-03-22

5.  Vaccination against Hepatitis B: A Scoping Review.

Authors:  Parimala Mohanty; Pratap Jena; Lipilekha Patnaik
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

Review 6.  Trends in Adult and Elderly Vaccination: Focus on Vaccination Practices in Tunisia and Morocco.

Authors:  Redouane Abouqal; Maher Beji; Mohamed Chakroun; Kamal Marhoum El Filali; Jihane Rammaoui; Hela Zaghden
Journal:  Front Public Health       Date:  2022-07-01

7.  The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers.

Authors:  D M MacDougall; B A Halperin; D MacKinnon-Cameron; Li Li; S A McNeil; J M Langley; S A Halperin
Journal:  BMJ Open       Date:  2015-09-29       Impact factor: 2.692

Review 8.  Vaccines for the elderly: current use and future challenges.

Authors:  Birgit Weinberger
Journal:  Immun Ageing       Date:  2018-01-22       Impact factor: 6.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.